{"id":"https://openalex.org/W2043804333","doi":"https://doi.org/10.1345/aph.1q487","title":"Clinical Experience with Ranolazine in a Veteran Population with Chronic Stable Angina","display_name":"Clinical Experience with Ranolazine in a Veteran Population with Chronic Stable Angina","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2043804333","doi":"https://doi.org/10.1345/aph.1q487","mag":"2043804333","pmid":"https://pubmed.ncbi.nlm.nih.gov/22215689"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1q487","doi":"https://doi.org/10.1345/aph.1q487","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1q487","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081986751","display_name":"Don N. Reeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104802","display_name":"Malcom Randall VA Medical Center","ror":"https://ror.org/01ew49p77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210104802","https://openalex.org/I4210118777","https://openalex.org/I4210119004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don N Reeder","raw_affiliation_strings":["Don N Reeder PharmD, Clinical Pharmacy Specialist, Malcom Randall Veterans Affairs Medical Center, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Don N Reeder PharmD, Clinical Pharmacy Specialist, Malcom Randall Veterans Affairs Medical Center, Gainesville, FL","institution_ids":["https://openalex.org/I4210104802"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael A Gillette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210104802","display_name":"Malcom Randall VA Medical Center","ror":"https://ror.org/01ew49p77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210104802","https://openalex.org/I4210118777","https://openalex.org/I4210119004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael A Gillette","raw_affiliation_strings":["Michael A Gillette PharmD BCPS, Post-Doctoral Fellow in Cardiology and Critical Care, Malcom Randall Veterans Affairs Medical Center; College of Pharmacy, University of Florida, Gainesville","College of Pharmacy, University of Florida, Gainesville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michael A Gillette PharmD BCPS, Post-Doctoral Fellow in Cardiology and Critical Care, Malcom Randall Veterans Affairs Medical Center; College of Pharmacy, University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4210104802"]},{"raw_affiliation_string":"College of Pharmacy, University of Florida, Gainesville","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046820230","display_name":"Andrew J. Franck","orcid":"https://orcid.org/0000-0003-3112-1334","observed_orcids":["https://orcid.org/0000-0003-3112-1334"]},"institutions":[{"id":"https://openalex.org/I4210104802","display_name":"Malcom Randall VA Medical Center","ror":"https://ror.org/01ew49p77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210104802","https://openalex.org/I4210118777","https://openalex.org/I4210119004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J Franck","raw_affiliation_strings":["Andrew J Franck PharmD BCPS, Clinical Pharmacy Specialist, Malcom Randall Veterans Affairs Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Andrew J Franck PharmD BCPS, Clinical Pharmacy Specialist, Malcom Randall Veterans Affairs Medical Center","institution_ids":["https://openalex.org/I4210104802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002582072","display_name":"David J. Frohnapple","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104802","display_name":"Malcom Randall VA Medical Center","ror":"https://ror.org/01ew49p77","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210104802","https://openalex.org/I4210118777","https://openalex.org/I4210119004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J Frohnapple","raw_affiliation_strings":["David J Frohnapple PharmD BCPS BCNSP, Director, Post-Doctoral Fellowship in Cardiology/Critical Care and Post-Graduate Year 2 Critical Care Residency; Clinical Pharmacy Specialist, Medical Intensive Care Unit/Total Parenteral Nutrition Service, Malcom Randall Veterans Affairs Medical Center","Clinical Pharmacy Specialist, Medical Intensive Care Unit/Total Parenteral Nutrition Service, Malcom Randall Veterans Affairs Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David J Frohnapple PharmD BCPS BCNSP, Director, Post-Doctoral Fellowship in Cardiology/Critical Care and Post-Graduate Year 2 Critical Care Residency; Clinical Pharmacy Specialist, Medical Intensive Care Unit/Total Parenteral Nutrition Service, Malcom Randall Veterans Affairs Medical Center","institution_ids":["https://openalex.org/I4210104802"]},{"raw_affiliation_string":"Clinical Pharmacy Specialist, Medical Intensive Care Unit/Total Parenteral Nutrition Service, Malcom Randall Veterans Affairs Medical Center","institution_ids":["https://openalex.org/I4210104802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I33213144","https://openalex.org/I4210104802"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.4158,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.69117994,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"46","issue":"1","first_page":"42","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10372","display_name":"Cardiac Imaging and Diagnostics","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranolazine","display_name":"ranolazine","score":1.0},{"id":"https://openalex.org/keywords/stable-angina","display_name":"stable angina","score":1.0},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.9340000152587891},{"id":"https://openalex.org/keywords/seattle-angina-questionnaire","display_name":"Seattle Angina Questionnaire","score":0.9559999704360962},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.859000027179718},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9580000042915344},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.5989999771118164},{"id":"https://openalex.org/keywords/refractory-angina","display_name":"refractory angina","score":0.6380000114440918},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C2779177932","wikidata":"https://www.wikidata.org/wiki/Q907104","display_name":"Ranolazine","level":2,"score":0.9653986692428589},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9525546431541443},{"id":"https://openalex.org/C2778425758","wikidata":"https://www.wikidata.org/wiki/Q180762","display_name":"Angina","level":3,"score":0.5157930850982666},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48195740580558777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4536055028438568},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3778986632823944},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.08436441421508789},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.06774196028709412}],"mesh":[{"descriptor_ui":"D000069458","descriptor_name":"Ranolazine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014728","descriptor_name":"Veterans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060050","descriptor_name":"Angina, Stable","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1345/aph.1q487","doi":"https://doi.org/10.1345/aph.1q487","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1q487","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:22215689","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22215689","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.929.2845","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.929.2845","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aop.sagepub.com/content/46/1/42.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.932.2928","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.932.2928","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aop.sagepub.com/content/46/1/42.full.pdf?legid%3Dspaop%26related-urls%3Dyes","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W3620260","https://openalex.org/W1477089198","https://openalex.org/W1538851845","https://openalex.org/W1576812268","https://openalex.org/W1603091860","https://openalex.org/W1970516435","https://openalex.org/W1975035031","https://openalex.org/W1976258949","https://openalex.org/W1976407595","https://openalex.org/W1981465069","https://openalex.org/W2032901385","https://openalex.org/W2045377209","https://openalex.org/W2048839939","https://openalex.org/W2049390983","https://openalex.org/W2052675653","https://openalex.org/W2055680411","https://openalex.org/W2059966673","https://openalex.org/W2065143069","https://openalex.org/W2067055418","https://openalex.org/W2077766494","https://openalex.org/W2082072065","https://openalex.org/W2084901371","https://openalex.org/W2085232374","https://openalex.org/W2089212168","https://openalex.org/W2089890051","https://openalex.org/W2098225712","https://openalex.org/W2099873623","https://openalex.org/W2104459538","https://openalex.org/W2109647832","https://openalex.org/W2110453810","https://openalex.org/W2126830306","https://openalex.org/W2148346557","https://openalex.org/W2166351234","https://openalex.org/W2887283102","https://openalex.org/W4211189027","https://openalex.org/W4256544323"],"related_works":["https://openalex.org/W2052675653","https://openalex.org/W2042905212","https://openalex.org/W1975165163","https://openalex.org/W1967735754","https://openalex.org/W7211890589","https://openalex.org/W2007125732","https://openalex.org/W4392864139","https://openalex.org/W1841246943","https://openalex.org/W2080169264","https://openalex.org/W7098731142"],"abstract_inverted_index":{"BACKGROUND:":[0],"Efficacy":[1],"of":[2,7,23,46,129,145,163,175,281],"ranolazine":[3,68,93,130,164,255],"in":[4,32,50,84,117,172,196,236,286],"the":[5,21,99,115,176,251],"treatment":[6,224,240,271],"chronic":[8],"stable":[9],"angina":[10,49,214,219,287],"(CSA)":[11],"has":[12],"been":[13],"established;":[14],"however,":[15],"pivotal":[16],"trials":[17],"did":[18,102],"not":[19,103],"require":[20],"optimization":[22],"conventional":[24],"antianginal":[25],"drug":[26,153],"therapy":[27],"(CADT)":[28],"prior":[29],"to":[30,43,122,165,185,259,269,278,291],"use":[31],"a":[33,51,71,79,95,105,292],"veteran":[34,52,293],"population.":[35],"OBJECTIVE:":[36],"To":[37],"determine":[38],"whether":[39],"ranolazine,":[40],"when":[41,289],"added":[42,277],"optimized":[44,166,279],"doses":[45,280],"CADT,":[47],"improves":[48],"population":[53,294],"with":[54,170,295],"CSA":[55],"and":[56,69,101,124,157,181,202,212,217,222,227,229,233],"refractory":[57],"symptoms.":[58],"METHODS:":[59],"In":[60],"an":[61,143,284],"observational":[62],"retrospective":[63],"study,":[64],"35":[65],"patients":[66,253,266],"prescribed":[67,92],"having":[70],"baseline":[72,106,121,186],"Seattle":[73],"Angina":[74],"Questionnaire":[75],"(SAQ)":[76],"administered":[77],"at":[78,146,179,200,272],"Veterans":[80],"Affairs":[81],"medical":[82],"center":[83],"Gainesville,":[85],"FL,":[86],"were":[87,91,108,206,242,257,267],"evaluated.":[88],"Patients":[89],"who":[90],"by":[94,247],"provider":[96],"from":[97,120,150],"outside":[98],"institution":[100],"obtain":[104],"SAQ":[107,118,177,197],"excluded.":[109],"The":[110,161],"primary":[111],"outcome":[112],"measure":[113],"was":[114,168],"change":[116],"scores":[119,178,187,199],"1":[123,180,201],"3":[125,182,203],"months":[126,183],"after":[127],"initiation":[128],"treatment.":[131],"Secondary":[132],"measures":[133],"included":[134],"clinically":[135,243],"significant":[136,244],"QTc":[137],"interval":[138],"prolongation":[139],"(>500":[140],"msec":[141,149],"or":[142],"increase":[144],"least":[147],"60":[148],"baseline),":[151],"adverse":[152],"reactions,":[154],"discontinuation":[155],"rates,":[156],"drug-drug":[158],"interactions.":[159],"RESULTS:":[160],"addition":[162],"CADT":[167,282],"associated":[169],"improvement":[171,285],"all":[173,192,237],"dimensions":[174],"compared":[184],"(p":[188],"<":[189],"0.001":[190],"for":[191],"dimensions).":[193],"Mean":[194],"changes":[195],"dimension":[198],"months,":[204],"respectively,":[205],"as":[207,245],"follows:":[208],"physical":[209],"limitation,":[210],"+9.86":[211],"+11.94;":[213],"stability,":[215],"+39.29":[216],"+32.69;":[218],"frequency,":[220],"+26.79":[221],"+25.38;":[223],"satisfaction,":[225,241],"+11.38":[226],"+10.66;":[228],"disease":[230],"perception,":[231],"+16.85":[232],"+18.59.":[234],"Improvments":[235],"dimensions,":[238],"except":[239],"defined":[246],"set":[248],"criteria.":[249],"Of":[250],"7":[252],"whose":[254],"dosages":[256],"increased":[258],"1000":[260],"mg":[261],"twice":[262],"daily,":[263],"only":[264],"2":[265],"able":[268],"maintain":[270],"that":[273],"dosage.":[274],"CONCLUSIONS:":[275],"Ranolazine":[276],"demonstrated":[283],"symptoms":[288],"given":[290],"persistent":[296],"CSA.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}